BACKGROUND: Cranial radiation therapy (CRT) is associated with declarative memory impairment and hippocampal volume loss in pediatric brain tumor survivors (PBTS). Animal studies suggest that this may reflect arrested neurogenesis in the dentate gyrus, the neurogenic region of the hippocampus. However, little is known about the distribution of CRT-induced volume loss across hippocampal subfields in humans and how this relates to memory. The goal of the present study was to characterize hippocampal subfield volume loss and relations to memory performance in PBTS. METHODS: MRI scans were obtained for 19 PBTS treated with CRT and 19 age- and sex-matched controls. An automated segmentation algorithm was used to segment hippocampi in each hemisphere into CA1, CA2/3, dentate gyrus (DG)/CA4, stratum radiatum/lacunosum/moleculare (SR/SL/SM) and subiculum. A subset of patients completed a paired associate verbal memory test from the Children's or Wechsler's Memory Scale (n = 11). RESULTS: Global hippocampal volumes were reduced bilaterally in PBTS (p = 0.002), but not all subfields differed significantly between groups. Bilateral DG/CA4 (p = 0.049) and SR/SL/SM (p = 0.019) were significantly smaller in patients. Diagnosis age in patients correlated with DG/CA4 (r = 0.57) and SR/SL/SM (r = 0.77) volumes, with younger diagnosis age predicting smaller volumes. Left DG/CA4 volume correlated with memory performance (r = 0.72), with smaller volume predicting poorer performance. CONCLUSION: Hippocampal subfields are differentially vulnerable to CRT, with DG/CA4 and SR/SL/SM displaying particular compromise. Patients diagnosed at younger ages may be at the greatest risk for volume loss. The brain-behavior relationship that we observed suggests that DG/CA4 compromise may contribute to impaired memory in PBTS.
. 2016 May 30;18(Suppl 3):iii158. doi: 10.1093/neuonc/now081.58
QOS-58: IMPACT OF CRANIAL RADIATION THERAPY ON HIPPOCAMPAL SUBFIELD VOLUMES AND DECLARATIVE MEMORY IN PEDIATRIC BRAIN TUMOR SURVIVORS
Alexandra Decker
1,2, Kamila Szulc
1, Jovanka Skocic
1, Cynthia de Medeiros
1, Lily Riggs
1, Eric Bouffet
3, Colleen Dockstader
1,2, Suzanne Laughlin
4, M Mallar Chakravarty
5,6, Donald Mabbott
1,2
Alexandra Decker
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
2Psychology, University of Toronto, Toronto, ON, Canada
Find articles by Alexandra Decker
Kamila Szulc
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
Find articles by Kamila Szulc
Jovanka Skocic
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
Find articles by Jovanka Skocic
Cynthia de Medeiros
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
Find articles by Cynthia de Medeiros
Lily Riggs
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
Find articles by Lily Riggs
Eric Bouffet
3Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada
Find articles by Eric Bouffet
Colleen Dockstader
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
2Psychology, University of Toronto, Toronto, ON, Canada
Find articles by Colleen Dockstader
Suzanne Laughlin
4Diagnositic Imaging, Hospital for Sick Children, Toronto, ON, Canada
Find articles by Suzanne Laughlin
M Mallar Chakravarty
5Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, QC, Canada
6Departments of Psychiatry and Biological and Biomedical Engineering, McGill University, Montreal, QC, Canada
Find articles by M Mallar Chakravarty
Donald Mabbott
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
2Psychology, University of Toronto, Toronto, ON, Canada
Find articles by Donald Mabbott
1Neurosciences and Mental Health, Hospital for Sick Children, Toronto, ON, Canada
2Psychology, University of Toronto, Toronto, ON, Canada
3Hematology/Oncology, Hospital for Sick Children, Toronto, ON, Canada
4Diagnositic Imaging, Hospital for Sick Children, Toronto, ON, Canada
5Cerebral Imaging Centre, Douglas Mental Health University Institute, Montreal, QC, Canada
6Departments of Psychiatry and Biological and Biomedical Engineering, McGill University, Montreal, QC, Canada
Issue date 2016 Jun.
© the author(s) 2016. published by oxford university press on behalf of the society for neuro-oncology. all rights reserved. for permissions, please e-mail: journals.permissions@oup.com
PMCID: PMC4903810
